In July, Bayer HealthCare announced the 2012 recipients of its Bayer Hemophilia Awards Program (BHAP), which funds innovative research and educational initiatives around the world. This year the company awarded approximately $2.3 million to 15 recipients in nine countries. Award categories include: Fellowship Project Award, Early Career Investigator Award, Special Project Award and the Caregiver Award.
Since its establishment in 2002, BHAP has awarded more than 200 grants, totaling more than $24 million, to researchers and caregivers from 29 countries around the world. BHAP support has resulted in more than 360 scientific abstracts, publications and presentations by awardees.
"The scientists and caregivers we honor today are performing the research needed to develop, for example, improved hemophilia therapies," said Prasad Mathew, MD, Vice President, Global Medical Affairs Hematology, Bayer HealthCare. "They are laying the groundwork for greater understanding of many aspects of hemophilia, and I look forward to seeing the results of their valuable work in the future."
